Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations45
Genetics and response to treatment with metformin for type 2 diabetes28
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing27
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review24
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization19
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1215
Patient comprehension of preemptive pharmacogenomic results14
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting13
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis13
Assessing patient understanding of pharmacogenomic test results: a qualitative study12
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans12
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level11
Rapid point of care testing: the next frontier in pharmacogenomics11
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications11
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison11
1.4981451034546